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 One out of three GP patients had received depression care from their GP 
 Higher age and lower educational level were associated with drug treatment 






Background. Depression is prevalent in general practice, but few studies have explored patient-reported 
depression care. 
Aim. To investigate patient-reported treatment received for depression and future treatment 
preferences among adult patients visiting their general practitioner (GP), and to evaluate the 
associations with sex, age, and educational level. 
Design and Setting. A cross-sectional survey was conducted in general practices in Norway from 2016 to 
2017. 
Methods. Altogether, 2335 consecutive patients (response rate, 89.2%) in the GPs’ waiting rooms 
answered a questionnaire about their received depression treatment and treatment preferences in case 
of future depression. 
Results. The study population (N=2239) had a mean age of 48.6 ± 17.7 years (range 18–91), 60.1% were 
women. Of the 770 patients reporting to have received depression treatment, 39.1% were treated 
exclusively by their GP while 52.5% also were referred to a psychologist/psychiatrist. Older age was 
positively associated with medication and negatively associated with referrals to 
psychologist/psychiatrist. People with high education had lower odds for receiving medication (OR, 0.49; 
95% CI: 0.30–0.80) compared to those with low education. If future depression, 81.6% of the 
respondents would discuss this with their GP, 60.9% would prefer talking therapy with their GP, 22.5% 
medication, and 52.9% referral to psychologist or psychiatrist. 
Conclusion. One third of the patients attending their GPs had consulted with them at some time 
concerning depression the case of future depression, most patients preferred talking therapy with the 
GP. This finding warrants an increased research focus on the GP’s role in depression care. 





Managing depression is challenging for society 1,2. The lifetime prevalence of depression in rural and 
urban Norway varies between 8.3% and 17.8%, respectively, and annual prevalence estimates vary 
between 3.7% and 7.3%, respectively 3,4, which is similar to Canadian figures 5. Because the first episode 
of depression tends to appear early in adult life, on average at the age of 30 years 6, and episodes often 
reoccur, depression contributes strongly to years lived with disability 7-9. The prevalence of depression is 
higher in women than in men, and in people with lower socioeconomic status (SES) compared to people 
with higher SES 3,4,8,10. 
In Norway, as in many other European countries, consultation with the GP is usually the first contact 
many have with health care for managing their mental health problems 11. In 2001, a patient-list system 
for GPs was introduced in Norway and 70% of the Norwegians consult their GP annually. About 130,000 
(33.7 per 1000) persons aged 20 years and older consulted their GP for depression according to the 
diagnoses recorded by GPs 12. Similar figures are found in Dutch general practices (28.5 per 1000 in 
2008) 13. The GPs’ main treatment options for depression are some sort of psychological treatment, 
antidepressant medication, and referral to psychologist or psychiatrist. Throughout this paper we use 
the term `talking therapy’ for GPs’ psychological treatment 14, including a wide variety of approaches 
from supportive talk as described by Malt et al 15 as `simple psychological treatment’ to counselling 16 
and acknowledged structured psychotherapeutic methods such as cognitive behavioral therapy. 
According to guidelines in UK and Norway, there should be a stepped-care approach, i.e. when initial 
care is unsuccessful, the GP refers the patient to a psychologist or psychiatrist for specialised mental 
health care. In such cases, the GP is supposed to continue following up the patient alongside treatment 
from other helpers 11,17,18. In Norway a referral from a GP is mandatory for refundable help from 
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psychologist or psychiatrist usually working together in hospitals, outpatient clinics, or practices that are 
private but contracted to the public health system.  
During the last decade, treatment with antidepressant drugs has increased and in 2015, they were 
issued to 7% of the general population in Norway 19. About 80% of antidepressants are prescribed by 
GPs, with higher prescription rates for women and older people 20. According to a Belgian study, about 
75% of patients with depression were prescribed antidepressants 21, but the corresponding figure for 
patients in Norway is unknown. 
In Norway, GPs have a key role in certifying sick leave. A register-based study revealed that GPs 
recorded a new episode of depression in approximately 2% of the employed adult population annually, 
and issued a sick-leave certificate to nearly half of them 22. However, the governmental policy is to focus 
on the positive mental health effects of staying at work, urging GPs to limit sick-leave certification1. 
A review of European community studies showed that only 26% of patients with a mental disorder had 
sought medical care 23. Patients’ understanding of their own symptoms, and their expectations and 
experiences of their GPs’ ability to help, have an impact on which issues they will raise in their 
consultations with the GP 24,25. Although several studies have shown that most patients would prefer 
psychotherapy rather than medications if in need of treatment for depression 26,27, few studies have 
examined what help patients with depression have received from their GP. The patient’s perspective on 
health-care delivery is important to improve health-care services and patients increasingly take part in 
decision-making regarding their health care 11,28. 
The aims of this study were to investigate patient-reported treatment received for patient-reported 
depression and future treatment preferences among adult patients visiting their GP, and further to 






We conducted a cross-sectional survey based on questionnaire data collected in general practices during 
the fall of 2016 and the spring of 2017. 
In their sixth year of medical study at the University of Bergen, all students are deployed in different 
general practices in Western Norway for a 4-week period. We instructed these students to collect 
questionnaire data from 20 consecutive patients aged 18 years and older sitting in GPs’ waiting rooms 
on random days during this period. The student (or secretary at the GP office) provided a letter 
presenting information about the study and a one-page questionnaire. The patients completed the 
questionnaire in the waiting room and returned it in a sealed envelope to the secretary. No 
compensation for study participation was granted. 
In total, 131 of 141 medical students collected data for the study, recruiting an average of 17.9 patients. 
The response rate of 89.2% was calculated on reports from 124 students. Seven students did not 
systematically report the number of patients who declined to participate. Of the 2335 completed 
questionnaires, 96 were excluded because the respondent’s age was missing (N=67) or the patients 
were younger than 18 years (N=29), which resulted in 2239 valid questionnaires comprising the study 
population. 
Measurements 
The one-page questionnaire was developed by experienced researchers and GPs (authors SR, ØH, BB, 
and SH) and contained questions about demographics, symptoms, treatment, contentment with 
treatment, and future preferences in relation to depression. The questionnaire also contained a short 
introductory text describing common symptoms and signs of depression, i.e., feeling down, hopeless, or 
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depressed, and/or experiencing little interest or pleasure in activities. We present data from the 
following questions in this paper: Previous involvement of GP (“Have you ever discussed with your GP 
that you were bothered with depression?”), depression treatment received (“What kind of help did you 
get from your GP?”) and future treatment preferences (“In case of future depression, what kind of help 
would you prefer?”). The previous involvement of the GP was reported as yes or no. The two questions 
regarding treatment received and preferred had seven answer options (i.e. talking therapy with GP, 
medication, sick-leave certification, referral to psychologist/psychiatrist, referral to psychomotor 
physiotherapist, no help, and other (free text, where the respondent could write freely) that allowed for 
the choice of more than one option. The future involvement of the GP (“In case of future depression, I 
would seek my GP”) was reported using single statements on a 5-point scale (fully agree, agree, neutral, 
disagree, or strongly disagree). The noninvolvement of the GP was reported using a single question (“If 
you have not discussed your depression with your GP, what was the reason?”) with six answer options (I 
have had no problems with depression, self-limiting conditions, the GP cannot help, I do not want to talk 
about depression, help from others, and other (free text) that allowed for the choice of more than one 
option. Demographic information (sex, age and educational level) was also included. Only a few patients 
completed the free-text options and their responses were not suitable for qualitative analysis. 
Statistical analysis 
The data were analyzed using descriptive statistical methods and comparing groups using the Pearson 
chi-square test. Logistic regression analyses were performed to examine the associations between 
patients’ sex, age, and educational level (independent variables) with depression treatment; male sex, 
age group 18–39 years, and primary school serving as references, and fully adjusted model presented. 
Logistic regression models were also used to analyze associations between previous treatment 
measures and preferred future treatment, using the same adjusting variables listed above. The effect 
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estimates are presented as odds ratios (OR) with 95% confidence intervals (CI). STATA software (version 
15; Stata Corp., College Station, TX, USA) was used and the level of significance was 0.05. 
 
RESULTS 
The study population comprised 2239 patients, mean age 48.6 ± 17.7 years (range 18–91 years), 60.1% 
were women (Table 1). Altogether, 770 (34.4%) patients reported that they had consulted their GP for 
depression, while 341 (15.2%) had dealt with depression without seeking help from their GP, 964 
(43.1%) had had no problems with depression, and 7.3% did not answer these questions. Of the 341 
patients that had dealt with depression without seeking help from their GP, 250 thought it were self-
limiting conditions, 68 did not want to talk about depression, 61 had sought help from others, and 21 
believed that their GP could not help.  
***INSERT TABLE 1 HERE**** 
Figure 1a shows the distribution of patient-reported depression treatment received from GPs. Of the 
770 patients who had sought help from their GP, 39.1% were managed in the general practice alone 
(talking therapy and/or medication and/or sick-leave certificate), while 52.5% were also referred to 
psychologist or psychiatrist. Altogether 44.7% patients reported single treatment options; 16.0% had 
received talking therapy with GP only, 12.6% medication only, and 16.1% referral to 
psychologist/psychiatrist only. The remaining 55.3% patients reported more than one treatment option, 
but we cannot report combinations of treatment since the responses may possibly refer to different 
depression episodes.  
***INSERT FIGURE 1 HERE**** 
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Older age was associated with more medication and fewer referrals to psychologist/psychiatrist (Table 
2). Medium education level was a predictor of talking therapy with the GP. Fewer patients with high 
education received medication (OR, 0.49; 95% CI: 0.30–0.80) compared to those with low education. For 
42% of patients in working age (18–67 years) the GP had issued a sick-leave certification related to 
depression and this was associated with medium (OR, 3.06; 95% CI: 1.66–5.61) or high education levels 
(OR, 3.04; 95% CI: 1.64–5.62), using low education as reference (not tabulated). 
***INSERT TABLE 2 HERE**** 
Of the 2239 patients, 81.6% fully agreed/agreed that they would seek their GP in case of depression in 
the future, 4% strongly disagreed/disagreed, and 14.3% gave a neutral response. Of 1782 respondents 
who stated their future treatment preferences (Figure 1b), 44.1% would choose treatment by GP only, 
talking therapy in particular, while 25.0% would prefer referral to psychologist/psychiatrist only and 
27.9% preferred to choose combinations of treatment by GP and psychologist/psychiatrist. 
Male sex, higher age, and lower education were associated with preference for talking therapy and 
medication, while female sex, lower age, and higher education predicted preference for referral (Table 
3).  
***INSERT TABLE 3 HERE**** 
Of the 770 patients reporting prior consultation with a GP for depression, 568 also answered the 
question about future treatment preferences. In adjusted logistic regression we found a marked positive 
association between prior treatment reported and future treatment option, most pronounced for GP 
talking therapy and medication (Table 4). Prior experience with talking therapy with GP was inversely 
association with future preference for referral (OR 0.4 (0.3-0.6)).  





Our study shows that one out of three patients surveyed in GPs’ waiting rooms had consulted their GP 
for depression. Half of these patients had been managed in general practice, while the other half had 
also been referred to psychologist or psychiatrist. Some 50% had received talking therapy with their GP, 
and a similar share had been treated with medication. Higher age and lower educational level predicted 
treatment with medication, while younger age was associated with referral. In case of future 
depression, most patients would consult their GP with a preference of talking therapy. Prior experience 
with talking therapy by GP markedly increased the odds for seeing this as a future option and also 
reduced the odds for a preference for referral in case of future depression. 
Strengths and limitations 
The sample size was large and comprised patients visiting many GP offices on random days. Age < 18 
years was the only exclusion criterion; therefore, the patients were representative of the adult patient 
population in general practices in Norway. Nevertheless, we must consider selection bias because the 
patients who were perceived as being able and willing to participate may have been asked preferably. 
Thus, the oldest and most disadvantaged patients may be underrepresented. The questionnaire was in 
the Norwegian language and immigrants were likely to have been excluded. 
The patients received a written introduction to the questionnaire describing the main symptoms of 
depression but these patients’ understanding of the concept of depression will vary and not necessarily 
align with diagnostic criteria. Information about symptoms that could describe severity of depression 
was not collected and the patients’ definition of depression may vary from symptoms not fulfilling 
diagnostic criteria to severe depression. Self-reported information is also vulnerable to recall-bias, 
especially for depression episodes in the past. Collecting diagnoses from GP could have increased the 
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precision compared to patient-reported diagnoses. On the other hand, GPs’ diagnoses are also 
unprecise when compared to a structured procedure using diagnostic tools, comprising both under- and 
overdiagnosis 29. Diagnostic uncertainty is a general problem regarding research in primary care. 
Many patients experience depression as a recurrent condition; therefore, the patient-reported 
treatment options may apply for different recent or past depression episodes, and do not necessarily 
represent treatment combinations. Associations with age should be interpreted with caution because 
we lack information about when the treatment reported was received. 
The present study is performed in a primary care system with GPs as first line service with a gate 
keeping role. Although the GP role varies between countries, GPs are generally the first line service 
dealing with a wide range of health problems, including psychological problems, and our results 
concerning depression care should be generalizable to countries with similar primary care models. 
Comparison with existing literature 
As a first-line easily accessible service offering continuity of care GPs are in position for actively using 
talking therapy. The patient-centered approach is a basis for GP work in general by listening to the 
patient’s concerns and discussing choice of treatment 30; a Danish study based on focus groups 
interviews showed that the GPs were clearly aware of such factors as active elements in their 
psychological approach to patients with mental health problems 31. Interestingly, Malt et al. found the 
effect of medication combined with talking therapy for depression in general practice comparable to 
treatment in specialized care 15. They denoted the taking therapy as “simple psychological treatment” 
and instructed the GPs to establish positive relationships, convey hope and optimism, giving the patients 
opportunity to discuss their feelings and fears and advising about physical activity.   
Half of the patients who had discussed depression with their GP reported treatment with medication, 
which is lower than the 70–85% found in international studies 5,13,21,32. In our study, we cannot relate 
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drug treatment to severity of depression; thus, this discrepancy can reflect the large share of patients 
with mild symptoms with no indication for antidepressants in our sample or reflect the differences in 
their GPs’ treatment habits. 
Every other patient treated by GPs was also referred to psychologist or psychiatrist. This finding 
challenges the often-described model for primary care, i.e., most mental health problems are managed 
exclusively in general practices 33. However, this finding must be considered as a longitudinal measure 
and not related to single depression episodes. In contrast to research on somatic health care in Norway, 
we found no variation in reported referral rates related to educational level. These findings align with a 
British study that found no variation in GPs’ depression treatment with patients’ SES 34. In contrast, we 
found less medication with higher educational level. Medication was also more commonly prescribed 
with increasing age, as found in other studies 13,20. In sum, the variations in depression care by GPs we 
found related to age, sex and educational level could reflect a socioeconomic inequity as shown by Jani 
et al 35, and warrants further research. 
Some 42% of those treated by a GP had received sick-leave certification, in line with the 43% frequency 
of sick leave with new episodes of depression found in a register study in Norway 22. However, the 
higher odds for sick leave with higher education is contradictory to the register study 22. An explanation 
might be lower work participation in the low educational group, but work participation is not accounted 
for in the present study. Interestingly, only 11% of the respondents had sick leave as a future treatment 
preference. This may encourage GPs to emphasize the benefit of work participation for patients with 
mental health problems 1. 
Implications for research and practice 
Half of the patients who had contacted their GP for depression reported talking therapy with their GP 
and these patients had a clear preference for talking therapy in case of a future depression episode. 
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There was a less marked association between prior referral and referral as a future treatment option, 
and prior talking therapy with GP significantly reduced the odd for referral as future treatment 
preference. This indicates that patients perceive GP talking therapy as valuable but there is a need for 
research into the contents and effect of different kinds of talking therapy with GPs. It is difficult to 
incorporate formal psychotherapeutic methods in general practices 31,36, but adapted methods for use in 
general practices have been shown to  improve quality of depression care 37,38. Even smaller 
improvement of care, reducing symptoms and improving function for patients with depression could 
have large societal effects because of the high prevalence. 
In line with earlier studies, we found a higher preference for talking therapy than for medication 26,39. 
However, we found that previous treatment with medication markedly increased odds for preferring 
medication in the future. GPs should consider such differences in treatment preferences to reduce 
treatment barriers 17. 
We found a partial consistency across sex, age, and educational level between treatment reported and 
future preferences. These findings may be a result of prior experiences and what is seen as possible to 
achieve and reflect inequality in treatment. However, different treatment options may better suit some 
patients than others and may reflect different values that should be considered when planning 
treatment according to a shared decision-making model 26-28. The GP must consider both aspects, i.e., to 
give the best treatment independently of sociodemographic status and to adapt care to personal 
preferences. However, what is the best treatment for a patient is not easy to predict 40 and our findings 





Based on patient reported data in a survey in GPs’ waiting rooms we found that one third of the patients 
attending their GP had consulted at some time concerning depression, half of them treated solely by GP 
while the other half also had been referred to a psychologist or psychiatrist. In the case of future 
depression, most patients preferred talking therapy with the GP, especially patients who had 
experienced this in prior depression episodes. These two results warrant an increased research focus on 
the GP’s role in depression care and the possibility of developing this role further. 
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Table 1. Patient characteristics in total study sample and subgroups according to patient-reported 
prior depression (N=2239) 
 Total sample  Subgroups used in analyses, or excluded 














No valid answers 
regarding depression 
care4 (N=164) 
 N %  % % % % 
Sex        
 Male         820 36.6  30.5 33.7 41.0 45.7 
 Female        1,346 60.1  66.6 61.9 55.7 51.8 
 Missing 73 3.3  2.9 4.4 3.3 2.5 
Age groups        
 18-39          779 34.8  37.1 51.3 29.8 18.9 
 40-59          792 35.4  42.3 27.3 33.4 31.1 
 60+         668 29.8  20.5 21.4 36.8 50.0 
Education level        
 Primary school 233 10.4  13.0 7.3 8.6 15.2 
 Secondary school 1,011 45.2  46.4 43.4 43.7 51.8 
 University college 
/ University 
930 41.5  38.8 46.6 44.4 26.8 
 Missing  65 2.9  1.8 2.7 3.3 6.1 
1 Patients ticking off one or more answers to the question: “What kind of help did you get from your GP?” 
2 Patients responding to the question “Why didn’t you involve your GP?” other than “I have had no problems 
with depression.“ 
3 Patients responding “I have had no problems with depression“ to the question “Why didn’t you involve your 
GP?” 






Table 2. The association between patient-reported treatment received from the GP and sex, 
age, and education level (N=736) 
  Talking therapy with 
GP  
Medication Referral to 
psychologist/psychiatrist   
  OR 95% CI OR 95% CI OR 95% CI 
Age       
 18-39 1  1  1  
 40-59 0.79 [0.56,1.10] 1.46* [1.05,2.04] 0.60** [0.43,0.85] 
 60+ 1.17 [0.77,1.78] 2.01** [1.32,3.07] 0.29*** [0.19,0.44] 
Sex       
 Men 1  1  1  
 Women 1.22 [0.89,1.67] 1.13 [0.82,1.55] 1.03 [0.74,1.42] 
Education level      
 Primary school 1  1  1  
 Secondary school 1.69* [1.06,2.71] 0.70 [0.43,1.13] 0.93 [0.58,1.50] 
 University college/ 
University 
1.26 [0.78,2.04] 0.49** [0.30,0.80] 1.17 [0.72,1.90] 
Multivariate logistic regression, OR = Odds ratio, CI = confidence interval 






Table 3: Patient-reported treatment preference in case of future depression according to sex, 
age, education level and prior depression (N=1782)  
  Talking therapy 
with GP 
Medication Referral to 
psychologist/ 
psychiatrist  
 N N (%) N (%) N (%) 
Sex     
 Female 1087 644 (47.9) 221 (20.3) 630 (58.0) 
 Male 643 417 (64.9) 168 (26.1) 281 (43.7) 
p-value1  0.021 0.005 <0.001 
Age     
 18-39 610 296 (48.5) 87 (14.3) 450 (73.8) 
 40-59 628 348 (61.2) 14 (22.5) 342 (54.5) 
 60+ 544 406 (74.6) 172 (31.6) 150 (27.6)  
p-value1  <0.001 <0.001 <0.001 
Educational level     
 Primary school 188 125 (66.5) 75 (39.9) 58 (30.9) 
 Secondary school 815 530 (65.0)  188 (23.1) 410 (50.3) 
 University college/University 743 404 (54.4) 125 (16.8) 466 (62.7) 
p-value1  <0.001 <0.001 <0.001 
Prior depression     
 Depression treated by GP  609 348 (57.1) 231 (37.9) 331 (54.4) 
 Depression not treated by GP 284 136 (47.9) 31 (10.9) 176 (62.0) 
 No prior depression 776 523 (67.4) 111 (14.3) 395 (50.9) 
p-value1  <0.001 <0.001 0.006 
Missing data for sex (N=52), education level (N= 36), prior depression (N=113) 





Table 4: The association between prior treatment received for depression and treatment preferences 
in case of future depression (N=586) 
  
Future treatment preferences 
 Talking therapy with GP Medication Referral to psychologist 
/psychiatrist 
 OR 95% CI OR 95% CI OR 95% CI 
Prior treatment 
options 
      
  Talking therapy         
with GP 
7.95*** [5.32,11.87] 0.94 [0.63,1.41] 0.42*** [0.29,0.60] 
  Medication 1.02 [0.69,1.50] 8.57*** [5.64,13.00] 0.87 [0.60,1.26] 
  Referral to 
psychologist 
/psychiatrist 
0.90 [0.60,1.31] 1.11 [0.74,1.67] 2.30*** [1.59,3.32] 
Multivariate logistic regression models adjusted for age, sex and educational level 
Exponentiated coefficients; 95% confidence intervals in brackets 





Caption FIGUR 1: 
Figure 1. a) Patient-reported depression treatment received from the GP (n=770)*; b) Patient-
reported treatment preferences in case of future depression (n=1782)* 
 
*More than one answer allowed per respondent 
 
